These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 11235821)

  • 1. Thalomid (Thalidomide) capsules: a review of the first 18 months of spontaneous postmarketing adverse event surveillance, including off-label prescribing.
    Clark TE; Edom N; Larson J; Lindsey LJ
    Drug Saf; 2001; 24(2):87-117. PubMed ID: 11235821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thalidomide: a review of approved and investigational uses.
    Matthews SJ; McCoy C
    Clin Ther; 2003 Feb; 25(2):342-95. PubMed ID: 12749503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thalidomide: new uses for an old drug].
    Wu KL; Sonneveld P
    Ned Tijdschr Geneeskd; 2002 Aug; 146(31):1438-41. PubMed ID: 12190008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of thalidomide in the management of erythema nodosum leprosum.
    Walker SL; Waters MF; Lockwood DN
    Lepr Rev; 2007 Sep; 78(3):197-215. PubMed ID: 18035771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalidomide in the treatment of erythema nodosum leprosum (ENL) in an outpatient setting: A five-year retrospective analysis from a leprosy referral centre in India.
    Upputuri B; Pallapati MS; Tarwater P; Srikantam A
    PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008678. PubMed ID: 33035210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-dependent thalidomide induced bradycardia in young erythema nodosum leprosum patient.
    Thangaraju P; Venkatesan S; Sivashanmugam E; Showkath Ali MK
    Indian J Pharmacol; 2019; 51(1):72-74. PubMed ID: 31031470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thalidomide: a remarkable comeback.
    Jacobson JM
    Expert Opin Pharmacother; 2000 May; 1(4):849-63. PubMed ID: 11249521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Japanese guideline on thalidomide usage in the management of erythema nodosum leprosum].
    Ishii N; Ishida Y; Okano Y; Ozaki M; Gidoh M; Kumano K; Goto M; Nogami R; Hatano K; Yamada A; Yotsu RR
    Nihon Hansenbyo Gakkai Zasshi; 2011 Sep; 80(3):275-85. PubMed ID: 21941834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalidomide: current and potential clinical applications.
    Calabrese L; Fleischer AB
    Am J Med; 2000 Apr; 108(6):487-95. PubMed ID: 10781782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe form of type 2 reaction in patients of Hansen's disease after withdrawal of thalidomide: case reports.
    Rattan R; Shanker V; Tegta GR; Verma GK
    Indian J Lepr; 2009; 81(4):199-203. PubMed ID: 20704076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of thromboembolic events associated with thalidomide in the non-cancer setting: a case report and review of the literature.
    Fabi SG; Hill C; Witherspoon JN; Boone SL; West DP
    J Drugs Dermatol; 2009 Aug; 8(8):765-9. PubMed ID: 19663116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thalidomide for erythema nodosum leprosum and other applications.
    Okafor MC
    Pharmacotherapy; 2003 Apr; 23(4):481-93. PubMed ID: 12680478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dermatologic and nondermatologic uses of thalidomide.
    Nasca MR; Micali G; Cheigh NH; West LE; West DP
    Ann Pharmacother; 2003 Sep; 37(9):1307-20. PubMed ID: 12921515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The return of thalidomide: can birth defects be prevented?
    Lary JM; Daniel KL; Erickson JD; Roberts HE; Moore CA
    Drug Saf; 1999 Sep; 21(3):161-9. PubMed ID: 10487395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thalidomide used by patients with erythema nodosum leprosum].
    Valente Mdo S; Vieira JL
    Rev Soc Bras Med Trop; 2010; 43(2):201-4. PubMed ID: 20464154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study].
    de Carsalade GY; Achirafi A; Flageul B
    Acta Leprol; 2003; 12(3):117-22. PubMed ID: 15040702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thalidomide levels in patients with erythema nodosum leprosum.
    Vieira JL; Valente Mdo S
    Ther Drug Monit; 2009 Oct; 31(5):602-3. PubMed ID: 19704404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, double-dummy, controlled dose comparison of thalidomide for treatment of erythema nodosum leprosum.
    Villahermosa LG; Fajardo TT; Abalos RM; Balagon MV; Tan EV; Cellona RV; Palmer JP; Wittes J; Thomas SD; Kook KA; Walsh GP; Walsh DS
    Am J Trop Med Hyg; 2005 May; 72(5):518-26. PubMed ID: 15891124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep vein thrombosis: a rare complication of thalidomide therapy in recurrent erythema nodosum leprosum.
    Sharma NL; Sharma V; Shanker V; Mahajan VK; Sarin S
    Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):483-5. PubMed ID: 15755204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions for erythema nodosum leprosum.
    Van Veen NH; Lockwood DN; van Brakel WH; Ramirez J; Richardus JH
    Cochrane Database Syst Rev; 2009 Jul; (3):CD006949. PubMed ID: 19588412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.